Of course, this data is retrospective and is subject to confounding and selection bias. Nonetheless, it is the most accurate information we have to date about the outcomes of patients treated with this disease. The ongoing prospective InPACT trial to study different treatments for advanced penile cancer will profoundly affect the future management of LN+ penile cancer. Our study can be used as a benchmark as treatment strategies mature following the InPACT trial.
Written by: Shreyas S. Joshi, MD Division of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, Pennsylvania
Read the Abstract
The Role of Extended Lymph Node Dissection in Radical Prostatectomy
Value of the Lymph Node Dissection in the M0 and M1 Patient
InPACT Trial - Answering the Unanswered Questions